The EURAS project received over 8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme
Rare neurodevelopmental disorders of the Ras pathway continue to evade effective treatment. The EURAS consortium has been awarded over 8 million euros from the Health Cluster of the Horizon Europe Research and Innovation Programme to develop new effective therapies and establish a framework for early, accurate diagnosis of neurological symptoms in a specific group of RASopathies (cardio-facio-cutaneous syndrome, Costello syndrome and SYNGAP1-related encephalopathy).
– The consortium will identify disease signatures, develop new and use existing disease models, identify and validate new therapeutic approaches and brain delivery systems and, with patient organisations from 13 countries, establish a patient registry for stratification and evaluation of therapeutic approaches, says group leader and Senior Research Fellow Michael Courtney from Turku Bioscience Centre, University of Turku. > Keep reading
> Read more about the consortium
There is a position available on this project, application deadline is on 19 June 2023.
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026